| The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease D Chabas, SE Baranzini, D Mitchell, CCA Bernard, SR Rittling, ... Science 294 (5547), 1731-1735, 2001 | 1081 | 2001 |
| IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. DO Willenborg, S Fordham, CC Bernard, WB Cowden, IA Ramshaw Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3223-3227, 1996 | 764 | 1996 |
| TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination J Liu, MW Marino, G Wong, D Grail, A Dunn, J Bettadapura, AJ Slavin, ... Nature medicine 4 (1), 78-83, 1998 | 689 | 1998 |
| High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial F Stéphan, B Barrucand, P Petit, S Rézaiguia-Delclaux, A Médard, ... Jama 313 (23), 2331-2339, 2015 | 583 | 2015 |
| Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis V Brundula, NB Rewcastle, LM Metz, CC Bernard, VW Yong Brain 125 (6), 1297-1308, 2002 | 546 | 2002 |
| Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis JL McQualter, R Darwiche, C Ewing, M Onuki, TW Kay, JA Hamilton, ... The Journal of experimental medicine 194 (7), 873-882, 2001 | 524 | 2001 |
| Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients JR Oksenberg, S Stuart, AB Begovich, RB Bell, HA Erlich, L Steinman, ... Nature 345 (6273), 344-346, 1990 | 514 | 1990 |
| Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis JR Oksenberg, MA Panzara, AB Begovich, D Mitchell, HA Erlich, ... Nature 362 (6415), 68-70, 1993 | 506 | 1993 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 483 | 2017 |
| MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies N Molnarfi, U Schulze-Topphoff, MS Weber, JC Patarroyo, T Prod’homme, ... Journal of Experimental Medicine 210 (13), 2921-2937, 2013 | 438 | 2013 |
| Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial A Hartemann, G Bensimon, CA Payan, S Jacqueminet, O Bourron, ... The lancet Diabetes & endocrinology 1 (4), 295-305, 2013 | 438 | 2013 |
| Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. NK De Rosbo, R Milo, MB Lees, D Burger, CC Bernard, A Ben-Nun The Journal of clinical investigation 92 (6), 2602-2608, 1993 | 415 | 1993 |
| B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions SE Baranzini, MC Jeong, C Butunoi, RS Murray, CCA Bernard, ... The Journal of Immunology 163 (9), 5133-5144, 1999 | 364 | 1999 |
| Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis CCA Bernard, TG Johns, A Slavin, M Ichikawa, C Ewing, J Liu, ... Journal of molecular medicine 75, 77-88, 1997 | 361 | 1997 |
| The structure and function of myelin oligodendrocyte glycoprotein TG Johns, CCA Bernard Journal of neurochemistry 72 (1), 1-9, 1999 | 345 | 1999 |
| Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy L Steinman, R Martin, C Bernard, P Conlon, JR Oksenberg Annual review of neuroscience 25 (1), 491-505, 2002 | 334 | 2002 |
| Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ... Annals of the rheumatic diseases 78 (2), 209-217, 2019 | 332 | 2019 |
| B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity MS Weber, T Prod'Homme, JC Patarroyo, N Molnarfi, T Karnezis, ... Annals of neurology 68 (3), 369-383, 2010 | 329 | 2010 |
| The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination T Karnezis, W Mandemakers, JL McQualter, B Zheng, PP Ho, KA Jordan, ... Nature neuroscience 7 (7), 736-744, 2004 | 313 | 2004 |
| Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis WH Robinson, P Fontoura, BJ Lee, HEN De Vegvar, J Tom, R Pedotti, ... Nature biotechnology 21 (9), 1033-1039, 2003 | 294 | 2003 |
